Corcept Therapeutics, Inc.
| Nasdaq: CORT
Corcept Therapeutics, Inc. is engaged in the development of drugs for the treatment of severe psychiatric, neurological and metabolic disorders in the United States. It focuses on the development of drugs for disorders that are associated with a steroid hormone called cortisol. The company's products include korlym, cushing's syndrome, CORT 108297 and weight gain mitigation. Corcept Therapeutics was founded by David B. Singer and Joseph K. Belanoff On May 13, 1998 by and is headquartered in Menlo Park, CA.